Cincinnati, OH, United States of America

Jon Isaacsohn

This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Cindome Pharma, LLC, Cinrx Pharma, LLC. Active years: 2019-2025.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jon Isaacsohn: Innovator in Pharmaceutical Compositions

Introduction

Jon Isaacsohn is a notable inventor based in Cincinnati, OH. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions and methods. With a total of 4 patents to his name, Isaacsohn's work focuses on enhancing the safety and efficacy of medical treatments.

Latest Patents

Isaacsohn's latest patents include groundbreaking work on deuterated domperidone compositions. These patents detail methods of synthesis, use, and dosing formulations that provide beneficial safety and other effects. His research aims to improve the therapeutic profile of existing medications, making them safer and more effective for patients.

Career Highlights

Throughout his career, Jon Isaacsohn has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Cinrx Pharma, LLC and Cindome Pharma, LLC. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to innovative projects.

Collaborations

Isaacsohn has worked alongside talented professionals such as Catherine Pearce and Piyush V Patel. These collaborations have further enriched his research and development efforts, leading to advancements in pharmaceutical compositions.

Conclusion

Jon Isaacsohn's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving medical treatments. His work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…